Yu-sheng Zhang

Des-Gamma-Carboxy Prothrombin (DCP) Antagonizes the Effects of Gefitinib on Human Hepatocellular Carcinoma Cells

Jia-Hui Chu, Xian-Jun Qu, S. Cui, 2015, Cellular Physiology and Biochemistry.

Des-γ-Carboxy Prothrombin (DCP) as a Potential Autologous Growth Factor for the Development of Hepatocellular Carcinoma

Jia-Hui Chu, Xian-Jun Qu, S. Cui, 2014, Cellular Physiology and Biochemistry.

A112, a tamibarotene dimethylaminoethyl ester, may inhibit human leukemia cell growth more potently than tamibarotene

Xian-Jun Qu, Wenfang Xu, X. Xue, 2012, Leukemia & lymphoma.

Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.

Zu-hua Gao, Xian-Jun Qu, Xiao-Fan Zhang, 2010, Cancer letters.

Deacetyl-mycoepoxydiene, isolated from plant endophytic fungi Phomosis sp. demonstrates anti-microtubule activity in MCF-7 cells.

Yue-Mao Shen, Yaojian Huang, Yu-sheng Zhang, 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Riccardin D-26, a synthesized macrocyclic bisbibenzyl compound, inhibits human hepatocellular carcinoma growth through induction of apoptosis in p53-dependent way.

Xian-Jun Qu, H. Lou, B. Yue, 2013, Cancer letters.

Natural dietary compound naringin prevents azoxymethane/dextran sodium sulfate-induced chronic colorectal inflammation and carcinogenesis in mice

Xian-Jun Qu, S. Cui, Yu-sheng Zhang, 2018, Cancer biology & therapy.

Inhibition of angiogenesis involves in anticancer activity of riccardin D, a macrocyclic bisbibenzyl, in human lung carcinoma.

Xian-Jun Qu, H. Lou, X. Xue, 2011, European journal of pharmacology.

Acetyl-11-keto-β-boswellic acid (AKBA) inhibits human gastric carcinoma growth through modulation of the Wnt/β-catenin signaling pathway.

Zu-hua Gao, Xian-Jun Qu, H. Lou, 2013, Biochimica et biophysica acta.

Naringin, a natural dietary compound, prevents intestinal tumorigenesis in ApcMin/+ mouse model

Xian-Jun Qu, Cong Li, Ye Li, 2016, Journal of Cancer Research and Clinical Oncology.